![Gina M. Wallar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Gina M.
Wallar worked as a Director at LabCorp Clinical Trials.
She then worked at NeoGenomics, Inc. as the President-Pharma Services Division from 2021 to 2022.
Dr. Wallar holds a doctorate degree from the University of California, Los Angeles.
Precedenti posizioni note di Gina M. Wallar
Società | Posizione | Fine |
---|---|---|
NEOGENOMICS, INC. | Corporate Officer/Principal | 27/05/2022 |
Labcorp Clinical Trials
![]() Labcorp Clinical Trials Hospital/Nursing ManagementHealth Services Labcorp Clinical Trials provides healthcare services. The company is headquartered in Hamburg, Germany. | Direttore/Membro del Consiglio | - |
Formazione di Gina M. Wallar
University of California, Los Angeles | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NEOGENOMICS, INC. | Health Services |
Aziende private | 1 |
---|---|
Labcorp Clinical Trials
![]() Labcorp Clinical Trials Hospital/Nursing ManagementHealth Services Labcorp Clinical Trials provides healthcare services. The company is headquartered in Hamburg, Germany. | Health Services |
- Borsa valori
- Insiders
- Gina M. Wallar